生物制剂药物

  • Sofosbuvir (Soforal)

    产物摘要:Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying.

    产物特征:

    产物名称 : Soforal
    通用名称 : Sofosbuvir
    主要因素 : 片剂
    包装规格 : 8’s
    优势 : 400 mg
    生产地 : 孟加拉
  • Ribavirin (Copeg)

    产物摘要:Ribavirin is an anti-viral drug indicated for severe RSV infection (individually), Hepatitis C infection (used in conjunction with Peginterferon) and other viral infections. Ribavirin is a prodrug, which when metabolized resembles purine RNA

    产物特征:

    产物名称 : Copeg
    通用名称 : Ribavirin
    主要因素 : 片剂
    包装规格 : 20’s
    优势 : 200 mg
    生产地 : 孟加拉
  • Peginterferon alfa 2a (Pegin)

    产物摘要:Pegylated interferon alfa-2a is an antiviral drug, has a dual mode of action both antiviral and on the immune system. The addition of polyethylene glycol to the interferon, through a process known as pegylation, enhances the half-life of the

    产物特征:

    产物名称 : Pegin
    通用名称 : Peginterferon alfa 2a
    主要因素 : Prefilled Injection
    包装规格 : 1’s
    优势 : 135mg and 180mg
    生产地 : 孟加拉
  • Erythropoietin (Eposis)

    产物摘要:Erythropoietin is an endogenous glycoprotein that stimulates red blood cell production. Erythropoietin alfa (rch) is purified from a Chinese hamster ovary cell line into which the gene coding for human erythropoietin has been inserted. The m

    产物特征:

    产物名称 : Eposis
    通用名称 : Erythropoietin
    主要因素 : Prefilled Injection
    包装规格 : 1’s
    优势 : 2000, 3000, 4000, 5000 IU
    生产地 : 孟加拉
  • Entecavir 0.5 mg (Caviral)

    产物摘要:Entecavir is a guanosine analogue with marked activity against HBV DNA polymerase. It is licensed for the treatment of chronic Hepatitis B virus infection in patients with compensated liver disease and evidence of acute viral replication, pe

    产物特征:

    产物名称 : Caviral
    通用名称 : Entecavir
    主要因素 : 片剂
    包装规格 : 1×10’s
    优势 : 0.5 mg
    生产地 : 孟加拉
  • Daclatasvir + Sofosbuvir (Darvoni)

    产物摘要:Sofosbuvir directly targets the Hepatitis C virus to stop it from making copies of itself in the liver. Sofosbuvir attaches itself to the genetic information, called RNA, to block the virus from multiplying. And Daclatasvir is a direct-actin

    产物特征:

    产物名称 : Darvoni
    通用名称 : Daclatasvir + Sofosbuvir
    主要因素 : 片剂
    包装规格 : 1×6’s
    优势 : Sofosbuvir 400 mg and Daclatasvir 60 mg
    生产地 : 孟加拉
  • Daclatasvir (Daclavir)

    产物摘要:Daclavir (Daclatasvir) is one of the new direct-acting antiviral drugs that target different steps of the hepatitis C virus (HCV) lifecycle. It is the first-ever approved HCV NS5A replication complex inhibitor, meaning it interferes with a p

    产物特征:

    产物名称 : Daclavir
    通用名称 : Daclatasvir
    主要因素 : 片剂
    包装规格 : 1×10’s
    优势 : 60 mg
    生产地 : 孟加拉
  • Tenofovir ( Becovir )

    产物摘要:TENOFOVIR is an antiretroviral agent which belongs to a class of drugs called nucleotide reverse transcriptase inhibitor or NtRTI. TENOFOVIR mimics a nucleoside base which blocks further construction of the virus. When combined with other

    产物特征:

    产物名称 : Becovir
    通用名称 : Tenofovir Disoproxil Fumarate
    主要因素 : 片剂
    包装规格 : 1×8’s
    优势 : 300 mg
    生产地 : 孟加拉
Show Buttons


    【网站地图】【sitemap】
    友情链接:正点游戏  凯发K8天生赢家一触即发  威尼斯144777欢迎您  麻将胡了网址  九游会集团  永利集团304am登录  亚美AM8AG  j9九游真人游戏平台  J9直营集团  77779193永利  amjs澳金沙门  asiagame